Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://zubairjfbk796017.p2blogs.com/37504813/trelaglutide-exploring-a-new-option-for-chronic-diseases